EUVIMEDEUVIMED entdecken
Fallbericht

Clofazimine-induced interstitial lung disease with haemoptysis during therapy for Mycobacterium abscessus pulmonary disease

Keishi Sugino, Hirotaka Ono, Mikako Saito, Seiji Igarashi

BMJ Case Reports · 2026

DOI: 10.1136/bcr-2025-270959 ↗

Kurz gefasst

Fallbericht in der Zeitschrift BMJ Case Reports, 2026. Verfasst von Keishi Sugino und 3 weiteren Autor:innen. Beteiligte Einrichtung: Respiratory Medicine, Tsuboi Hospital, Koriyama, Japan ks115108@tsuboi-hp.or.jp. Hauptthemen laut MEDLINE: Hemoptysis, Mycobacterium Infections, Nontuberculous, Clofazimine, Mycobacterium abscessus. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 9 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We report a woman in her late 60s with a 6-month history of productive cough, low-grade fever and fatigue. Bronchoscopy yielded Mycobacterium abscessus , and she was diagnosed with M. abscessus pulmonary disease. She initially received intravenous imipenem and amikacin plus oral clarithromycin for 1 month, followed by maintenance therapy with clarithromycin and clofazimine (CFZ). One year after starting CFZ, she developed high fever, worsening cough, exertional dyspnoea and haemoptysis. Chest high-resolution CT revealed bilateral upper-lobe predominant reticular ground-glass opacities, bronchovascular and interlobular septal thickening, and focal consolidation. Bronchoscopy demonstrated reddish purple bronchoalveolar lavage fluid with brownish precipitates, and histology showed macrophages laden with crystalline material, consistent with CFZ deposition. CFZ was discontinued, leading to clinical recovery and radiographic resolution within 1 month. This case illustrates CFZ-induced lung injury presenting with haemoptysis during therapy for M. abscessus pulmonary disease. Clinicians should be aware of this rare but significant complication, particularly in patients receiving long-term CFZ.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HemoptysisMycobacterium Infections, NontuberculousClofazimineMycobacterium abscessusLung Diseases, InterstitialAnti-Bacterial AgentsHumansFemaleMiddle AgedTomography, X-Ray ComputedBronchoscopyClarithromycin

Stichwörter der Autor:innen

Drugs and medicinesInterstitial lung diseasePharmacology and therapeuticsRespiratory medicineRespiratory system

Substanzen

ClofazimineAnti-Bacterial AgentsClarithromycin

Autor:innen und Institutionen

  • Respiratory Medicine, Tsuboi Hospital, Koriyama, Japan ks115108@tsuboi-hp.or.jp.
  • Respiratory Medicine, Tsuboi Hospital, Koriyama, Fukushima, Japan.
  • Pathology, Tsuboi Hospital, Koriyama, Fukushima, Japan.

Zitieren

APA

Sugino, K., Ono, H., Saito, M., & Igarashi, S. (2026). Clofazimine-induced interstitial lung disease with haemoptysis during therapy for Mycobacterium abscessus pulmonary disease. BMJ Case Reports. https://doi.org/10.1136/bcr-2025-270959

Vancouver

Sugino K, Ono H, Saito M, Igarashi S. Clofazimine-induced interstitial lung disease with haemoptysis during therapy for Mycobacterium abscessus pulmonary disease. BMJ Case Reports. 2026. doi:10.1136/bcr-2025-270959

BibTeX
@article{Sugino2026,
  author = {Sugino, Keishi and Ono, Hirotaka and Saito, Mikako and Igarashi, Seiji},
  title = {Clofazimine-induced interstitial lung disease with haemoptysis during therapy for Mycobacterium abscessus pulmonary disease},
  journal = {BMJ Case Reports},
  year = {2026},
  doi = {10.1136/bcr-2025-270959}
}
Kostenlos starten →